Evidence map›Paper›PMID 39083597›Full record

ArticleScience advances2024

Multiplexed mapping of the interactome of GPCRs with receptor activity-modifying proteins.

Ilana B Kotliar, Annika Bendes, Leo Dahl, Yuanhuang Chen, Marcus Saarinen, Emilie Ceraudo, Tea Dodig-Crnković, Mathias Uhlén, Per Svenningsson, Jochen M Schwenk and 1 more

Abstract read
In one paragraph

Article in Science advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. GPCR drug discovery: new agents, targets and indications.Nature reviews. Drug discovery · 2025
    Review
  4. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Ilana B KotliarLaboratory of Chemical Biology and Signal Transduction, The Rockefeller University, New York, NY, USA.ORCID 0000-0001-9533-4828
Annika BendesScience for Life Laboratory, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH Royal Institute of Technology, Solna, Sweden.ORCID 0000-0001-9329-2353
Leo DahlScience for Life Laboratory, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH Royal Institute of Technology, Solna, Sweden.ORCID 0000-0003-1492-3052
Yuanhuang ChenLaboratory of Chemical Biology and Signal Transduction, The Rockefeller University, New York, NY, USA.ORCID 0000-0001-7404-5170
Marcus SaarinenDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Emilie CeraudoLaboratory of Chemical Biology and Signal Transduction, The Rockefeller University, New York, NY, USA.ORCID 0000-0001-6563-9751
Tea Dodig-CrnkovićScience for Life Laboratory, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH Royal Institute of Technology, Solna, Sweden.ORCID 0000-0002-2875-896X
Mathias UhlénScience for Life Laboratory, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH Royal Institute of Technology, Solna, Sweden.ORCID 0000-0002-4858-8056
Per SvenningssonDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0001-6727-3802
Jochen M SchwenkScience for Life Laboratory, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH Royal Institute of Technology, Solna, Sweden.ORCID 0000-0001-8141-8449
Thomas P SakmarLaboratory of Chemical Biology and Signal Transduction, The Rockefeller University, New York, NY, USA.ORCID 0000-0002-2836-8953

Funding

Tri-Institutional PhD Program in Chemical BiologyT32GM136640 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI DEREK S TAN · 2020 to 2026
$2.4M
NIGMS NIH HHS T32 GM136640
6 · The paper itself

Abstract

Receptor activity-modifying proteins (RAMPs) form complexes with G protein-coupled receptors (GPCRs) and may regulate their cellular trafficking and pharmacology. RAMP interactions have been identified for about 50 GPCRs, but only a few GPCR-RAMP complexes have been studied in detail. To elucidate a comprehensive GPCR-RAMP interactome, we created a library of 215 dual epitope-tagged (DuET) GPCRs representing all GPCR subfamilies and coexpressed each GPCR with each of the three RAMPs. Screening the GPCR-RAMP pairs with customized multiplexed suspension bead array (SBA) immunoassays, we identified 122 GPCRs that showed strong evidence for interaction with at least one RAMP. We screened for interactions in three cell lines and found 23 endogenously expressed GPCRs that formed complexes with RAMPs. Mapping the GPCR-RAMP interactome expands the current system-wide functional characterization of RAMP-interacting GPCRs to inform the design of selective therapeutics targeting GPCR-RAMP complexes.

Indexed as

Protein BindingReceptor Activity-Modifying ProteinsReceptors, G-Protein-CoupledHEK293 CellsHumansProtein Interaction MappingProtein Interaction MapsReceptor Activity-Modifying ProteinsReceptors, G-Protein-Coupled

Identifiers

PMID39083597
PMCPMC11290489

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.